DGAP-News

Balda AG: Stable growth during first nine months of 2013 / 2014 - Seite 2

operations of EUR 1.3 million in the reporting period following a loss of
EUR -0.6 million in the previous year.

After tax, the Group reports EUR 10.4 million of earnings from its
continuing operations (comparable period: EUR 11.9 million).


Performance of the operating segments

With its Balda America segment the company generated EUR 29.2 million sales
revenue in the first nine months of 2013 / 2014 and in the prior year
period EUR 11.6 million. In the current reporting period the US companies
are fully integrated while in the previous year only three months were
consolidated. The segment EBITDA stood at EUR 1.7 million (prior-year
period: EUR 0.2 million).

The segment Europe generated EUR 21.9 million of sales revenue for the
period under review (previous year: EUR 28.0 million). The segment reported
a slight loss of EUR -0.3 million at the EBITDA level (prior year period:
profit of EUR 0.5 million) due to extraordinary items.

General holding company costs led to a slight loss of EUR -0.1 million at
the EBITDA level in the Other segment after EUR -0.4 million in the
previous year.


Outlook

The Management Board is retaining the forecasts for the full 2013 / 2014
year: Assuming that macroeconomic conditions do not deteriorate
significantly and barring any other unforeseeable adverse effects that have
a material impact on the Balda Group, the company assumes that it will
generate consolidated sales revenue in the EUR 70 million to EUR 80 million
range, accompanied by a single-digit EBITDA margin and a profit. Earnings
are strongly dependent on currency effects.

For additional information, please see the section entitled "Opportunities
and anticipated developments" in our Annual Report for the 2012 / 2013
financial year.

Further and more detailed information can be found on the website of Balda
AG: www.balda-group.com


Contact
Michael Pfister
Deekeling Arndt Advisors
Tel: [phone]
Mail: [e-mail]


About Balda
Balda is a provider of first-class solutions in plastics for demanding,
high-quality applications in the fields of healthcare, lifestyle,
automotive and consumer electronics industries. Balda has operating
divisions in Europe and America and maintains state-of-the-art production
facilities at its headquarter in Bad Oeynhausen, Germany as well as in the
USA. The success of Balda, which employs around 700 people, is based on the
deployment of leading-edge, cost-effective technologies, coupled with the
trust-based and close collaboration with customers. The Balda AG share
(ISIN: DE0005215107) is listed on the SDAX segment of Deutsche Börse.

www.balda-group.com
www.balda-medical-group.com


End of Corporate News

---------------------------------------------------------------------

14.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: Balda AG
Bergkirchener Str. 228
32549 Bad Oeynhausen
Germany
Phone: [phone] / 9 22-0
Fax: [phone]
E-mail: [e-mail]
Internet: www.balda.de
ISIN: DE0005215107
WKN: 521510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,
München, Stuttgart


End of News DGAP News-Service
---------------------------------------------------------------------
268224 14.05.2014